Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.35 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.35 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.35 |
| ▸ | BCHE | P06276 | 1/20 | 0.35 |
| ▸ | GPR3 | P46089 | 2/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | DRD1 | P21728 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 3/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2480013 | 0.74 | GPR3 (0.43) | ACHESLC22A2SLC22A3BCHEGPR3 | |
| SCHEMBL29596197 | 0.74 | GPR3 (0.43) | ACHESLC22A2SLC22A3BCHEGPR3 | |
| SCHEMBL7048563 | 0.74 | GPR3 (0.43) | ACHESLC22A2SLC22A3BCHEGPR3 | |
| SCHEMBL7056977 | 0.74 | GPR3 (0.43) | ACHESLC22A2SLC22A3BCHEGPR3 | |
| SCHEMBL7627897 | 0.74 | ACHE (0.34) | ACHESLC22A2SLC22A3BCHEGPR3 | |
| SCHEMBL19960583 | 0.73 | — | — | |
| SCHEMBL19960575 | 0.72 | — | — | |
| SCHEMBL17697954 | 0.71 | ACHE (0.32) | ACHEBCHECHRM2HTR1AADRA2A | |
| SCHEMBL6672398 | 0.71 | GPR3 (0.40) | ACHESLC22A2SLC22A3BCHEGPR3 | |
| SCHEMBL19960587 | 0.70 | HTR6 (0.33) | HTR2ACHRM2CHRM1SLC6A2ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180079841-A1 | METALLOCENE SUPPORTED CATALYST AND METHOD FOR PREPARING POLYOLEFIN USING THE SAME | LG CHEM, LTD. (KR) | 2018-03-22 | — | — | US | disclosed |
| US-20180072822-A1 | METALLOCENE COMPOUND | LG CHEM, LTD. (KR) | 2018-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180079841-A1 | METALLOCENE SUPPORTED CATALYST AND METHOD FOR PREPARING POLYOLEFIN USING THE SAME | PCBP1, SOD1, PCLAF | ACHE 2516/4885SLC22A2 4658/4885SLC22A3 4751/4885 |
| US-20180072822-A1 | METALLOCENE COMPOUND | SOD1, PCNA, OR10J3 | ACHE 1937/4885SLC22A2 3567/4885SLC22A3 3817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.